WHO ICTRP trial
Clinical study to compare two creams with the active substance imiquimod and one…
EUCTR2016-000712-15-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-000712-15-DE |
|---|---|
| Public title | Clinical study to compare two creams with the active substance imiquimod and one cream without active substance for patients with actinic keratosis |
| Scientific title | Double-blind, randomised clinical study comparing efficacy and safety of Imiquimod 5% Cream (Test) vs. Aldara® 5% Cream (Reference) vs. Vehicle in patients with actinic keratosis |
| Primary sponsor | Dermapharm AG |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | Germany |
| Conditions | Actinic keratosis MedDRA version: 20.0 Level: PT Classification code 10000614 Term: Actinic keratosis System Organ Class: 10040785 - Skin and subcutaneous tissue disorders ;Therapeutic area: Diseases [C] - Skin and Connective Tissue… |
| Interventions | Product Name: Imiquimod 5% cream Pharmaceutical Form: Cream INN or Proposed INN: IMIQUIMOD CAS Number: 99011-02-6 Current Sponsor code: n.a. Other descriptive name: Imiquimod Concentration unit: % (W/W) percent weight/weight Concentration… |
| Registration date | Oct 14, 2016 |
| Target size | 426 |
| Secondary IDs | 16-04/Imi-C |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: